Drospirenone / Ethinyl Estradiol / Inert Ingredients
Also known as: Drospirenone-Ee, Jasmiel, Lo-Zumandimine, Loryna, Nikki, Ocella, Syeda 28, Vestura, Yasmin 28, Yaz 28, Zumandimine.
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Class |
|---|---|---|---|
| 3-0.02 MG | Tablet | $0.189 / unit | Generic |
| 3-0.03 MG | Tablet | $0.154 / unit | Generic |
| 3 MG-0.02 MG | Tablet | $0.189 / unit | Generic |
| 3 MG-0.03 MG | Tablet | $0.154 / unit | Generic |
| — | Tablet | $0.154 / unit | Generic |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price.
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $14,536,037 gross for Drospirenone / Ethinyl Estradiol / Inert Ingredients across 552,272 prescriptions (measured, national).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS